Evaluation of new care pathways for elderly patients with atrial fibrillation
EHRA-PATHS: Addressing Multimorbidity in Elderly Atrial Fibrillation Patients Through Interdisciplinary, Patient-centred Systematic Care Pathways - Clinical and Health Economic Evaluation of New Care Pathways
This study is testing new care plans for older adults with atrial fibrillation to see if they can improve health outcomes and lower healthcare costs.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1300 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | University Medical Center Groningen Academic / other |
| Locations | 1 site (Groningen) |
| Trial ID | NCT05773768 on ClinicalTrials.gov |
What this trial studies
This study focuses on elderly patients diagnosed with atrial fibrillation (AF), who often have multiple comorbidities that complicate their treatment. It aims to develop and implement new care pathways that address these complexities, moving away from the traditional single-disease approach. By utilizing the EHRA-PATHS software tool, the study will evaluate current management practices and assess the effectiveness of the newly developed pathways in improving patient outcomes and reducing healthcare costs.
Who should consider this trial
Good fit: Ideal candidates for this study are elderly individuals aged 65 and older who have been newly diagnosed with atrial fibrillation.
Not a fit: Patients whose atrial fibrillation is triggered by specific conditions or who have a life expectancy of less than one year may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of elderly patients with atrial fibrillation and their comorbidities, enhancing their overall health outcomes.
How similar studies have performed: While this approach is innovative in its focus on multimorbidity in elderly AF patients, similar studies have shown promise in improving care pathways for complex patient populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Newly diagnosed atrial fibrillation (paroxysmal, persistent or permanent) * ≥65 years of age * Willing and able to participate and to attend the scheduled follow-up visits. Exclusion Criteria: * Atrial fibrillation episode was due to a trigger (i.e. postoperative, infection, hyperthyroidism etc.) * Life expectancy of less than 1 year * Participation in another clinical study (registry studies not included) * Severe cognitive impairment / dementia (defined based on MMSE and CDR scoring systems)
Where this trial is running
Groningen
- University Medical Center Groningen — Groningen, Netherlands (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.